Pathophysiological determinants of worse stroke outcome in atrial fibrillation

Cerebrovascular Diseases

Volumn 30, Issue 4, 2010, Pages 389-395

  Tu, Hans T H ^a   Campbell, Bruce C V ^a   Christensen, Soren ^b   Collins, Marnie ^b   De Silva, Deidre A ^a,h   Butcher, Kenneth S ^g   Parsons, Mark W ^e   Desmond, Patricia M ^b   Barber, P Alan ^f   Levi, Christopher R ^e   Bladin, Christopher F ^d   Donnan, Geoffrey A ^c   Davis, Stephen M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

^g UNIVERSITY OF ALBERTA   (Canada)

^h NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

Atrial fibrillation; Pathophysiology of stroke; Penumbra imaging; Perfusion MRI; Stroke MRI; Stroke outcome

Indexed keywords

AGE DISTRIBUTION; AGED; ARTERY OCCLUSION; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHO PLANAR IMAGING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERFUSION; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; REPERFUSION; STROKE;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ATRIAL FIBRILLATION; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 77955194620     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316886     Document Type: Article

References (31)

1. Fuster V, Ryden L, Cannom D, Crijns H, Curtis A, Ellenbogen K, Halperin J, Le Heuzey J, Kay G, Lowe J, Olsson S, Prystowsky E, Tamargo J, Wann S, Smith S Jr, Jacobs A, Adams C, Anderson J, Antman E, Hunt S, Nishimura R, Ornato J, Page R, Riegel B, Priori S, Blanc J, Budaj A, Camm A, Dean V, Deckers J, Despres C, Dickstein K, Lekakis J, Mc-Gregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano J, American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
2. Kolominsky-Rabas P, Weber M, Gefeller O, Neundoerfer B, Heuschmann P: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740.
3. Candelise L, Pinardi G, Morabito A, the Italian Acute Stroke Study Group: Mortality in acute stroke with atrial fibrillation. Stroke 1991;22:169-174.
4. Sandercock P, Bamford J, Dennis M, Burn J, Slattery J, Jones L, Boonyakarnkul S, Warlow C: Atrial fibrillation and stroke: prevalence in difference types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). BMJ 1992;305:1460-1465.
5. Jorgensen H, Nakayama H, Reith J, Rasschou H, Olsen T: Acute stroke with atrial fibrillation: The Copenhagen Stroke Study. Stroke 1996;27:1765-1769.
6. Kaarisalo M, Immonen-Raiha P, Marttila R, Salomaa V, Kaarsalo E, Salmi K, Sarti C, Sivenius J, Torppa J, Tuomilehto J: Atrial fibrillation and stroke: mortality and causes of death after the first acute ischemic stroke. Stroke 1997;28:311-315.
7. Kimura K, Minematsu K, Yamaguchi T, for the Japan Multicenter Stroke Investigators' Collaboration: Atrial fibrillation as a predictive factor for severe stroke and early death in 15, 831 patients with acute ischemic stroke. J Neurol Neurosurg Psychiatry 2005;76:679-683.
8. Miyasaka Y, Barnes M, Gersh B, Cha S, Bailey K, Abhayaratna W, Seward J, Tsang T: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-125.
9. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T: Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci 2008;267:57-61.
10. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford G, Grond M, Hacke W, Hennerici M, Kaste M, Kohrmann M, Larrue V, Lees K, Machnig T, Roine R, Toni D, Vanhooren G, for the SITSMOST Investigators: Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomised controlled trials: SITSMOST. Stroke 2008;39:3316-3322.
11. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V, Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P, Silvestrelli G: Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008;39:2249-2256.
12. Kammersgaard L, Olsen T: Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc Dis 2005;21:187-193.
13. Weimar C, Ziegler A, Konig I, Diener H, on behalf of the German Stroke Study Collaborators: Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002;249:888-895.
14. Baird T, Parsons M, Phanh T, Butcher K, Desmond P, Tress B, Colman P, Chambers B, Davis S: Persistent post stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
15. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, Lanari A, Micheli S, Bertolani L, Venti M, Palmerini F, Billeci A, Comi G, Previdi P, Silvestrelli G: Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis 2009;28:119-123.
16. Davis S, Donnan G, Parsons M, Levi C, Butcher K, Peeters A, Barber P, Bladin C, De Silva D, Chalk J, Fink J, Kimber T, Schultz D, Hand P, Frayne J, Hankey G, Muir K, Gerraty R, Tress B, Desmond P, for the EPITHET investigators: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial: a placebocontrolled randomised trial. Lancet Neurol 2008;7:299-309.
17. Ostergaard L, Weisskoff R, Chesler D, Gyldensted C, Rosen B: High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. 1. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
18. Hacke W, Albers G, Bogousslavsky J, Davalos A, Fischer M, Furlan A, Kaste M, Lees K, Soehngen M, Warach S: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
19. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with rt-PA for acute stroke (ECASS). JAMA 1995;274:1017-1025.
20. max threshold for predicting penumbral tissue in acute stroke. Stroke 2009;40:469-475.
21. Bang O, Saver J, Alger J, Starkman S, Ovbiagele B, Liebeskind D, for the UCLA Collateral Investigators: Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke. Neurology 2008;71:1804-1811.
22. Barber P, Darby D, Desmond P, Yang Q, Gerraty R, Jolley D, Donnan G, Tress B, Davis S: Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426.
23. Hand P, Wardlaw J, Rivers C, Armitage P, Bastin M, Lindley R, Dennis M: MR diffusion weighted imaging and outcome prediction after ischemic stroke. Neurology 2006;66:1159-1163.
24. Miteff F, Levi C, Bateman G, Spratt N, McElduff P, Parsons M: The independent predictive utility of CT angiographic collateral status in acute ischemic stroke. Brain 2009;132:2231-2238.
25. Kannel W, Abbott R, Savage D, McNamara P: Epidemiologic features of chronic AF. The Framingham Study. N Engl J Med 1982;306:1018-1022.
26. Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995:98; 476-484.
27. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P: Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980;11:35-38.
28. Molina C, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J: Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004;35:486-490.
29. Dzialowski I, Pexman J, Barber P, Demchuk A, Buchan A, Hill M: Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in CASES registry. Stroke 2007;38:75-79.
30. Campbell C, Christensen S, Butcher K, Gordon I, Parsons M, Desmond P, Barber P, Levi C, Bladin C, De Silva D, Donnan G, Davis S: Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010;41:82-88.
31. Prosser J, MacGregor L, Lees K, Diener H, Hacke W, Davis S, on behalf of the VISTA Investigators: Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007;38:2295-2302.